Lower toxicity with targeted anticancer agents in phase I trials

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2012年 / 1416卷 / 1期
关键词：
Independent Predictor; Component Variable; National Cancer Institute; Anticancer Agent; Advanced Cancer;
D O I：
10.2165/00128415-201214160-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [31] Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer
    Arkenau, Hendrik-Tobias
    Brunetto, Andre T.
    Barriuso, Jorge
    Olmos, David
    Eaton, David
    de Bono, Johann
    Judson, Ian
    Kaye, Stan
    ONCOLOGY, 2009, 76 (03) : 151 - 156
  • [32] Improving the design of phase II trials of cytostatic anticancer agents
    Stone, Andrew
    Wheeler, Catherine
    Barge, Alan
    CONTEMPORARY CLINICAL TRIALS, 2007, 28 (02) : 138 - 145
  • [33] Seamless Phase I-II Trial Design for Assessing Toxicity and Efficacy for Targeted Agents
    Hoering, Antje
    LeBlanc, Mike
    Crowley, John
    CLINICAL CANCER RESEARCH, 2011, 17 (04) : 640 - 646
  • [34] Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan
    Forster, Martin D.
    Saijo, Nagahiro
    Seymour, Lesley
    Calvert, Hilary
    CLINICAL CANCER RESEARCH, 2010, 16 (06) : 1737 - 1744
  • [35] Use of body surface area and body weight in dosing of new anticancer agents in phase I trials
    Leveque, Dominique J.
    Gigou, Luc
    Beretz, Laurence
    Bergerat, Jean Pierre
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Ocular Toxicity of Targeted Anticancer Agents (vol 81, pg 771, 2021)
    Fortes, Blake H.
    Tailor, Prashant D.
    Dalvin, Lauren A.
    DRUGS, 2022, 82 (03) : 355 - 355
  • [37] Anticancer Agents Targeted to Sirtuins
    Kozako, Tomohiro
    Suzuki, Takayoshi
    Yoshimitsu, Makoto
    Arima, Naomichi
    Honda, Shin-ichiro
    Soeda, Shinji
    MOLECULES, 2014, 19 (12) : 20295 - 20313
  • [38] TARGETED TOXINS AS ANTICANCER AGENTS
    SIEGALL, CB
    CANCER, 1994, 74 (03) : 1006 - 1012
  • [39] The ethics of phase I trials of biologic agents
    Stephen B Hanauer
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 533 - 533
  • [40] The ethics of phase I trials of biologic agents
    Hanauer, Stephen B.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (10): : 533 - 533
12345